Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECS-II: Dexamethasone in Cardiac Surgery
NCT03002259Phase 4Unknown
- Start
- Sep 2018
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexamethasone in inflammatory response (2 arms). Primary endpoint: Days alive and at home up to 30 days after surgery. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
inflammatory response
Beyond the preview
Go deeper on NCT03002259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03002259.